Personal information

Activities

Collapse all

Works (5)

Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

Risk Management and Healthcare Policy
2024-04 | Journal article
DOI: 10.2147/RMHP.S455897
Contributors: Zeyu Xie; Jia Hu; Mengting Li; Xiao Hu; Jisheng Chen
Source: check_circle
Crossref

Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review

Clinical Epidemiology
2022-12 | Journal article
DOI: 10.2147/CLEP.S391819
Contributors: Zeyu Xie; Sensen Yang; Weishang Deng; Jinjian Li; Jisheng Chen
Source: check_circle
Crossref

Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis

Medicine
2022-11-25 | Journal article
DOI: 10.1097/md.0000000000031807
Part of ISSN: 1536-5964
Contributors: Zeyu Xie; Sensen Yang; Weishang Deng; Zeyu Xie; Jisheng Chen
Source: Self-asserted source
Zeyu Xie

A Health Technology Assessment Based on Chinese Guidelines: Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Type 2 Diabetes Complicated with Cardiovascular Disease

Therapeutics and Clinical Risk Management
2022-08 | Journal article
DOI: 10.2147/TCRM.S375067
Contributors: Zeyu Xie; Jinjian Li; Sensen Yang; Weishang Deng; Jisheng Chen
Source: check_circle
Crossref

Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China

Expert Review of Pharmacoeconomics & Outcomes Research
2022-08-03 | Journal article
DOI: 10.1080/14737167.2022.2107506
Part of ISSN: 1473-7167
Part of ISSN: 1744-8379
Contributors: Zeyu Xie
Source: Self-asserted source
Zeyu Xie
How many people are using ORCID?